Eosinophilic Esophagitis Management

Initial Assessment and Treatment

For patients with eosinophilic esophagitis presenting with painful swallowing and inability to eat solid food, immediate management should include IV hydration, proton pump inhibitor therapy, and consultation with gastroenterology for endoscopic evaluation and possible dilation if strictures are present, with a plan for IV fluid administration to maintain hydration, as recommended by the American Gastroenterological Association 1
Urgent endoscopy is indicated for patients with food impaction or severe dysphagia, and should include assessment for strictures, furrows, rings, or other EoE-related changes, and biopsies from multiple levels of the esophagus (at least 6 biopsies from different anatomical sites), as recommended by the American Gastroenterological Association 1

First-line therapy with 40-80 mg daily of omeprazole or equivalent should be continued for 8-12 weeks before assessing response, as recommended by the American College of Gastroenterology, with a response rate of approximately 40% 1, 2, 3
Second-line therapy with topical corticosteroids, such as swallowed fluticasone or budesonide, achieves histologic remission in ~65% of patients and reduces inflammation and associated pain symptoms, as per the American Academy of Allergy, Asthma, and Immunology 2, 3
Repeat endoscopy with biopsy while on treatment (8-12 weeks) to assess histologic response is necessary, as symptoms correlate poorly with histologic activity, as stated by the American College of Gastroenterology 1
Maintenance therapy is required due to high recurrence rates, and follow-up endoscopies are necessary to monitor disease activity even if symptoms improve, according to the American Gastroenterological Association 1, 4

Consider dietary therapy in consultation with a dietitian for long-term management, as prolonged dysphagia can lead to nutritional deficiencies and weight loss, as recommended by the American College of Gastroenterology 1
Dietary therapy with food elimination diets removes food allergens triggering inflammation and may provide significant symptom relief, including pain, as suggested by the American Gastroenterological Association 2, 3
Nutritional assessment and support may be needed, as recommended by the American College of Gastroenterology 1

Endoscopic dilation is recommended for patients with dysphagia from EoE-associated strictures, providing symptom improvement in 87% of patients, and should be performed with a conservative approach to minimize complications, as suggested by the American Society for Gastrointestinal Endoscopy 2
Gentle technique with serial dilation in 1-3mm increments and targeting a final diameter of 15-18mm is recommended, as per the American Society for Gastrointestinal Endoscopy 5
Post-dilation pain management is crucial, as 74% of patients experience chest pain after dilation procedures, and prophylactic analgesia may be warranted before and after dilation, according to the American Society for Gastrointestinal Endoscopy 2
The most common adverse event is post-procedure chest pain, and perforation risk is low (0.4%) with modern techniques, according to the American College of Gastroenterology 5

Conservative analgesic measures, such as acetaminophen for mild to moderate pain, should be used, while avoiding NSAIDs when possible as they may irritate the esophageal mucosa, as recommended by the American College of Gastroenterology 2
Treatment should focus on addressing the underlying inflammation with appropriate medical therapy while providing symptomatic relief through conservative analgesic measures, as recommended by the American Gastroenterological Association 2, 3

Relying solely on symptom improvement is not recommended, as symptoms may improve while inflammation persists, leading to progressive fibrosis, according to the American Gastroenterological Association 1, 4
Inadequate endoscopic sampling, with less than 6 biopsies from different esophageal locations, can lead to inaccurate diagnosis, as stated by the American Gastroenterological Association 1
Failure to address both inflammation and strictures can lead to inadequate treatment, and a combined approach with anti-inflammatory therapy and dilation may be necessary, as recommended by the American Gastroenterological Association 1
Complete histologic remission (<5 eosinophils/hpf) should be considered a treatment target, although the specific guideline society recommendation is not provided 2